DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,950,349 | +4.0% | 64,290 | +0.6% | 4.03% | +11.1% |
| Q2 2023 | $15,340,800 | -4.5% | 63,920 | +0.3% | 3.62% | -11.2% |
| Q1 2023 | $16,065,030 | +96735.6% | 63,740 | +2.0% | 4.08% | -12.3% |
| Q4 2022 | $16,590 | -99.9% | 62,505 | -0.3% | 4.65% | +0.9% |
| Q3 2022 | $16,191,000 | +1.8% | 62,685 | -0.0% | 4.61% | +4.3% |
| Q2 2022 | $15,897,000 | -13.6% | 62,705 | 0.0% | 4.42% | +6.6% |
| Q1 2022 | $18,393,000 | -10.9% | 62,705 | -0.1% | 4.15% | -2.9% |
| Q4 2021 | $20,642,000 | +8.1% | 62,740 | 0.0% | 4.27% | -0.3% |
| Q3 2021 | $19,101,000 | +13.4% | 62,740 | 0.0% | 4.28% | +13.2% |
| Q2 2021 | $16,837,000 | +19.2% | 62,740 | 0.0% | 3.79% | +11.9% |
| Q1 2021 | $14,122,000 | +1.3% | 62,740 | -0.1% | 3.38% | -0.5% |
| Q4 2020 | $13,946,000 | +3.2% | 62,780 | 0.0% | 3.40% | -6.6% |
| Q3 2020 | $13,519,000 | +21.8% | 62,780 | 0.0% | 3.64% | +9.0% |
| Q2 2020 | $11,101,000 | +27.8% | 62,780 | 0.0% | 3.34% | -0.9% |
| Q1 2020 | $8,689,000 | -9.8% | 62,780 | 0.0% | 3.37% | +5.4% |
| Q4 2019 | $9,635,000 | +6.1% | 62,780 | -0.1% | 3.20% | -0.8% |
| Q3 2019 | $9,079,000 | +1.1% | 62,855 | 0.0% | 3.23% | +3.0% |
| Q2 2019 | $8,984,000 | +8.3% | 62,855 | 0.0% | 3.13% | +4.4% |
| Q1 2019 | $8,298,000 | +28.0% | 62,855 | 0.0% | 3.00% | +7.4% |
| Q4 2018 | $6,482,000 | -5.1% | 62,855 | 0.0% | 2.80% | +12.3% |
| Q3 2018 | $6,830,000 | +10.1% | 62,855 | 0.0% | 2.49% | +0.4% |
| Q2 2018 | $6,203,000 | +0.8% | 62,855 | 0.0% | 2.48% | +2.1% |
| Q1 2018 | $6,154,000 | +5.5% | 62,855 | 0.0% | 2.43% | +5.4% |
| Q4 2017 | $5,834,000 | +11.3% | 62,855 | +2.9% | 2.30% | +11.8% |
| Q3 2017 | $5,241,000 | +1.6% | 61,105 | 0.0% | 2.06% | +0.9% |
| Q2 2017 | $5,157,000 | -1.3% | 61,105 | 0.0% | 2.04% | -3.9% |
| Q1 2017 | $5,226,000 | +62.7% | 61,105 | +48.0% | 2.12% | +49.6% |
| Q4 2016 | $3,213,000 | -0.7% | 41,280 | 0.0% | 1.42% | +2.1% |
| Q3 2016 | $3,236,000 | +79.6% | 41,280 | +131.4% | 1.39% | +73.0% |
| Q2 2016 | $1,802,000 | +6.5% | 17,840 | 0.0% | 0.80% | +4.7% |
| Q1 2016 | $1,692,000 | – | 17,840 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |